Corrigendum to “design, Synthesis and Characterization of Novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3h-quinazoline-4-one Derivatives As Inhibitors of NF-κB and AP-1 Mediated Transcription Activation and As Potential Anti-Inflammatory Agents” [eur J Med Chem 44 (2009) 2184–2189]